Press Releases

Media Focus

2025 pharma predictions


What are the trends shaping biopharma in 2025? ADC Process Development Director Song Young Kim shares his insights on overcoming ADC manufacturing and supply chain challenges. 


"Since ADCs consist of an antibody, a cytotoxic payload, and a chemical linker, companies tend to rely on different vendors for each component, complicating the supply chain. 


Biotech and pharmaceutical companies are overcoming these challenges by partnering with CDMOs that have specialized facilities for ADC manufacturing and the analytical capabilities necessary to support every step of the journey."


Read more in the latest Pharma Manufacturing article.


What are the trends shaping biopharma in 2025? ADC Process Development Director Song Young Kim shares his insights on overcoming ADC manufacturing and supply chain challenges. 


"Since ADCs consist of an antibody, a cytotoxic payload, and a chemical linker, companies tend to rely on different vendors for each component, complicating the supply chain. 


Biotech and pharmaceutical companies are overcoming these challenges by partnering with CDMOs that have specialized facilities for ADC manufacturing and the analytical capabilities necessary to support every step of the journey." 


Read more in the latest Pharma Manufacturing article.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION